TL;DR
This study reveals that in gastric cancer, low oxygen levels (hypoxia) suppress a microRNA called miR-598-3p, which in turn promotes cancer cell metastasis by shifting their energy production from efficient oxidative phosphorylation to less efficient glycolysis. Restoring miR-598-3p levels or inhibiting glycolysis effectively suppresses metastasis, offering a potential therapeutic strategy.
What Problem Does This Paper Address?
Gastric cancer is notorious for its rapid growth and tendency to metastasize. A key characteristic of many cancers, including gastric cancer, is a metabolic shift towards glycolysis, even when oxygen is available (the Warburg effect). This metabolic reprogramming is thought to fuel cancer cell proliferation and survival. However, the specific mechanisms by which this shift is promoted in metastatic gastric cancer cells, particularly under hypoxic conditions (common in tumors due to rapid growth outstripping blood supply), remain poorly understood. MicroRNAs (miRNAs) are known to play significant roles in cancer development, but their precise involvement in hypoxia-driven metabolic changes and subsequent metastasis in gastric cancer is an open question. This paper aims to elucidate the role of miRNAs in this process, specifically focusing on how hypoxia influences their expression and, consequently, the metabolic state and metastatic potential of gastric cancer cells.
Methods
The researchers employed a multi-pronged approach to investigate the role of miR-598-3p in gastric cancer metastasis under hypoxic conditions:
- miRNA Profiling: They used miRNA chip analysis to identify miRNAs that were differentially expressed in gastric cancer cells under normoxic versus hypoxic conditions.
- Quantitative Real-Time PCR (qPCR): This standard technique was used to validate the expression levels of specific miRNAs, including miR-598-3p, and to measure the expression of target genes.
- Cell Culture and Transfection: Gastric cancer cell lines (MKN45, SGC-7901, BGC-823) were cultured and manipulated using transfection with plasmids to overexpress or silence specific miRNAs (e.g., miR-598-3p mimics, miR-598-3p sponges) or target genes.
- In Vitro Assays:
- Wound-healing assay: To assess cell migration.
- Transwell assay: To evaluate cell invasion.
- Glucose consumption and lactate production assays: To measure glycolytic activity.
- ATP level measurement: To assess overall cellular energy production.
- ATP source analysis: To differentiate between ATP produced via glycolysis versus oxidative phosphorylation.
- In Vivo Assays:
- Pulmonary and peritoneal metastasis assays: Using immunodeficient mice (BALB/c nude mice) injected with engineered gastric cancer cells to assess the formation of metastatic nodes in the lungs and peritoneal cavity.
- Kaplan-Meier survival analysis: To evaluate the impact of interventions on animal survival.
- Western Blotting: To measure the protein levels of key molecules, including EMT markers (E-cadherin, N-cadherin, Vimentin, Fibronectin, Snail, Slug) and glycolytic enzymes (HK2, PKM2, GLUT1, LDHA).
- Dual-Luciferase Reporter Assay: To confirm direct binding of miR-598-3p to the 3' untranslated regions (3'UTRs) of its predicted target genes.
- RNA Sequencing (RNA-seq): To identify differentially expressed genes in response to miR-598-3p manipulation.
- Gene Set Enrichment Analysis (GSEA): To identify enriched biological pathways associated with differentially expressed genes.
Datasets
The study utilized established gastric cancer cell lines (MKN45, SGC-7901, BGC-823) and primary patient samples (20 gastric cancer patients) for analysis. No new public datasets were introduced or used for training/evaluation in this paper.
Key Insights and Ideas
- Hypoxia is a key driver of miR-598-3p downregulation: The study clearly demonstrates that low oxygen conditions, prevalent in tumors, lead to a significant decrease in miR-598-3p expression in gastric cancer cells. This is a crucial link between the tumor microenvironment and miRNA regulation.
- miR-598-3p acts as a brake on glycolysis: The research shows that miR-598-3p normally restricts glycolysis. When its levels are low (due to hypoxia), glycolysis is ramped up, leading to increased ATP production through this less efficient pathway.
- Metabolic shift fuels metastasis: The increased reliance on glycolysis under hypoxic conditions, driven by the loss of miR-598-3p, is directly linked to enhanced cell migration, invasion, and ultimately, metastasis. This highlights the critical role of metabolic reprogramming in cancer progression.
- RMP and IGF1r are direct targets of miR-598-3p: The study identifies RMP (Ribosomal protein L23a-binding protein) and IGF1r (Insulin-like growth factor 1 receptor) as direct targets of miR-598-3p. The downregulation of miR-598-3p leads to the upregulation of these proteins, which in turn promote glycolysis and metastasis.
- Targeting glycolysis is a viable therapeutic strategy: The use of R406, a compound that promotes oxidative phosphorylation (anti-Warburg effect), effectively suppressed metastasis, even when miR-598-3p was depleted. This suggests that interfering with the glycolytic shift can be a potent anti-metastatic strategy.
Key Results
- Hypoxia downregulates miR-598-3p: miRNA chip analysis revealed 6 downregulated miRNAs under hypoxia, with miR-598-3p being a key one, validated by qPCR.
- miR-598-3p overexpression suppresses metastasis: Overexpressing miR-598-3p in gastric cancer cells significantly reduced their migration and invasion in vitro and inhibited metastatic node formation in vivo (pulmonary and peritoneal metastasis assays). It also prolonged survival in mice.
- Silencing miR-598-3p promotes metastasis: Using a "sponge" to inhibit endogenous miR-598-3p increased cell migration, invasion, and metastatic node formation in vivo, while shortening survival.
- miR-598-3p targets RMP and IGF1r: Dual-luciferase reporter assays confirmed direct binding of miR-598-3p to the 3'UTRs of RMP and IGF1r. Overexpression of RMP or IGF1r could rescue the anti-metastatic effects of miR-598-3p.
- miR-598-3p suppresses glycolysis: Overexpression of miR-598-3p reduced glucose uptake and lactate production, shifting ATP production towards oxidative phosphorylation. Conversely, silencing miR-598-3p increased glycolysis.
- Therapeutic interventions are effective: Treatment with R406 (promoting OXPHOS) or UK5099 (inhibiting glycolysis) modulated the metabolic shift and suppressed metastasis.
Limitations and Future Work
- HIF1a independence: While hypoxia is known to activate HIF1a, the study found that miR-598-3p downregulation was not dependent on HIF1a accumulation. The precise upstream regulators of miR-598-3p under hypoxia warrant further investigation.
- Reciprocal influence of non-cancer cells: The study primarily focuses on cancer cell-intrinsic mechanisms. The influence of other cells in the tumor microenvironment (e.g., immune cells, fibroblasts) on hypoxia-driven metastasis and the role of miR-598-3p in this context were not explored.
- Clinical translation: While the findings suggest miR-598-3p as a therapeutic target, further research is needed to develop effective delivery methods for synthetic miR-598-3p mimics or other therapeutic strategies in a clinical setting.
- Computational modeling: The authors mention that future experimental and computational modeling could further elucidate these mechanisms.
Summary updated